مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

201
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Anti HLA Antibodies in Hemato-oncologic Patients with and without Platelet Refractoriness

Pages

  79-86

Abstract

 Background and Objectives: Various antibodies such as antibodies against RBC antigens, anti-HLA, and anti-platelet antibodies are developed after repeated blood transfusions and may lead to transfusion reactions such as platelet refractoriness in recipients. In this study, anti-HLA antibodies were evaluated in hemato-oncological patients, with and without simultaneous platelet refractoriness Materials and Methods: In this descriptive study, performed from 2017 to 2019, presence of anti-HLA antibodies in patients with hemato-oncological disorders, referred to the HSCT Research Center, Shariati Hospital, Tehran, was assessed using Panel Reactive Antibody (PRA) test based on complement lymphocytotoxicity. Data analysis was performed by SPSS (version 16) and chisquare tests. Results: Of 79 studied patients with hemato-oncological disorders including 34 females (43%) and 45 males (57%) with the age range of 2 to 83 years, 49 were platelet refractory and 30 were not. Anti-HLA antibodies were present in 39 (49. 4%) patients and 40 (50. 6%) were negative for them. The frequency of panel reactive antibody positive cases was significantly different between patients with platelet refractoriness (62. 8%) and those without it (30%) (P = 0. 007). Conclusions: The role of anti-HLA antibodies in platelet refractoriness is well established. Our study also showed a significant difference in this regard among two groups of hemato-oncological patients with and without platelet refractoriness. The presence of these antibodies does not always mean platelet refractoriness, and antibodies without the ability to activate complement can also cause this complication.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SHAIEGAN, M., Mostakhdemin Hosseini, M., ALAEI, M., EBRAHIMZADEH, E., CHEGINI, A., & MOHAMMADI, S.. (2021). Anti HLA Antibodies in Hemato-oncologic Patients with and without Platelet Refractoriness. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), 18(2 ), 79-86. SID. https://sid.ir/paper/413471/en

    Vancouver: Copy

    SHAIEGAN M., Mostakhdemin Hosseini M., ALAEI M., EBRAHIMZADEH E., CHEGINI A., MOHAMMADI S.. Anti HLA Antibodies in Hemato-oncologic Patients with and without Platelet Refractoriness. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON)[Internet]. 2021;18(2 ):79-86. Available from: https://sid.ir/paper/413471/en

    IEEE: Copy

    M. SHAIEGAN, M. Mostakhdemin Hosseini, M. ALAEI, E. EBRAHIMZADEH, A. CHEGINI, and S. MOHAMMADI, “Anti HLA Antibodies in Hemato-oncologic Patients with and without Platelet Refractoriness,” THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), vol. 18, no. 2 , pp. 79–86, 2021, [Online]. Available: https://sid.ir/paper/413471/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button